Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001731122-25-000783·ADC Therapeutics SA
Schedule 13G ownership disclosure
ADC THERAPEUTICS SA
Common Shares, par value CHF 0.08 per share · CUSIP: H0036K147
Event date: 2025-05-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- HPWH TH AG
Shares: 8,670,588.00 · Class: 8.52%
- Dr. Hans-Peter Wild
Shares: 9,788,944.00 · Class: 9.61%
- Thomas Pfisterer
Shares: 173,899.00 · Class: 0.17%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001731122-25-000783
- Form type
- SCHEDULE 13G/A
- Filer
- ADC Therapeutics SA
- CIK
- CIK 1771910
- Filed
- May 19, 2025
- Reporting period
- May 15, 2025
- Description
- Schedule 13G beneficial ownership